These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 21818920)
41. Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features. Alberti C G Chir; 2010; 31(11-12):568-74. PubMed ID: 21232206 [TBL] [Abstract][Full Text] [Related]
42. Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate. Shah IA; Schlageter MO; Stinnett P; Lechago J Mod Pathol; 1991 Mar; 4(2):220-4. PubMed ID: 1710806 [TBL] [Abstract][Full Text] [Related]
43. Acid mucin and high molecular weight cytokeratin in prostatic lesions: evaluation of a combined histochemical and immunohistochemical stain. Gal R; Halpern M; Koren R; Rath-Wolfson L; Klein B; Siegal A Br J Urol; 1995 Jul; 76(1):57-60. PubMed ID: 7544206 [TBL] [Abstract][Full Text] [Related]
44. Nephrogenic adenoma of the prostatic urethra involving the prostate gland: a clinicopathologic and immunohistochemical study of eight cases. Malpica A; Ro JY; Troncoso P; Ordoñez NG; Amin MB; Ayala AG Hum Pathol; 1994 Apr; 25(4):390-5. PubMed ID: 7512941 [TBL] [Abstract][Full Text] [Related]
49. [About morphology and classification of tumor-like and malignant prostatic lesions]. Anichkov NM; Plotnikova NA Arkh Patol; 2001; 63(5):44-50. PubMed ID: 11765416 [TBL] [Abstract][Full Text] [Related]
50. A case of primary combined neuroendocrine carcinoma with squamous cell carcinoma in the upper gingiva. Mochizuki Y; Omura K; Sakamoto K; Nakanishi S; Satoh K; Marukawa E; Yamaguchi A Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):e34-9. PubMed ID: 20303044 [TBL] [Abstract][Full Text] [Related]
51. Neuroendocrine cells in benign prostatic hyperplasia and prostatic carcinoma: effect of hormonal treatment. Guate JL; Escaf S; Menendez CL; del Valle M; Vega JA Urol Int; 1997; 59(3):149-53. PubMed ID: 9428430 [TBL] [Abstract][Full Text] [Related]
52. Superficial primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical analysis of 15 cases. Lu J; Xue LY; Lu N; Zou SM; Liu XY; Wen P Dis Esophagus; 2010 Feb; 23(2):153-9. PubMed ID: 19515193 [TBL] [Abstract][Full Text] [Related]
53. Neuroendocrine differentiation in carcinomas of the prostate: do neuroendocrine serum markers reflect immunohistochemical findings? Angelsen A; Syversen U; Haugen OA; Stridsberg M; Mjølnerød OK; Waldum HL Prostate; 1997 Jan; 30(1):1-6. PubMed ID: 9018329 [TBL] [Abstract][Full Text] [Related]
54. Prostate carcinoma with amphicrine features: further refining the spectrum of neuroendocrine differentiation in tumours of primary prostatic origin? Prendeville S; Al-Bozom I; Compérat E; Sweet J; Evans AJ; Ben-Gashir M; Mete O; van der Kwast TH; Downes MR Histopathology; 2017 Dec; 71(6):926-933. PubMed ID: 28756619 [TBL] [Abstract][Full Text] [Related]
55. The expression of keratins, vimentin, neurofilament proteins, smooth muscle actin, neuron-specific enolase, and synaptophysin in tumors of the specific glands in the canine anal region. Vos JH; van den Ingh TS; Ramaekers FC; Molenbeek RF; de Neijs M; van Mil FN; Ivanyi D Vet Pathol; 1993 Jul; 30(4):352-61. PubMed ID: 8212457 [TBL] [Abstract][Full Text] [Related]
56. Neuroendocrine stains and proliferative indices of prostatic adenocarcinomas in transurethral resection samples. Speights VO; Cohen MK; Riggs MW; Coffield KS; Keegan G; Arber DA Br J Urol; 1997 Aug; 80(2):281-6. PubMed ID: 9284203 [TBL] [Abstract][Full Text] [Related]
57. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. De Marzo AM; Meeker AK; Epstein JI; Coffey DS Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039 [TBL] [Abstract][Full Text] [Related]
58. NeuroD1 expression in human prostate cancer: can it contribute to neuroendocrine differentiation comprehension? Cindolo L; Franco R; Cantile M; Schiavo G; Liguori G; Chiodini P; Salzano L; Autorino R; Di Blasi A; Falsaperla M; Feudale E; Botti G; Gallo A; Cillo C Eur Urol; 2007 Nov; 52(5):1365-73. PubMed ID: 17126478 [TBL] [Abstract][Full Text] [Related]
59. Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells. Zhou M; Shah R; Shen R; Rubin MA Am J Surg Pathol; 2003 Mar; 27(3):365-71. PubMed ID: 12604893 [TBL] [Abstract][Full Text] [Related]
60. Basal cell carcinoma of the prostate: unusual subtype of prostatic carcinoma. Komura K; Inamoto T; Tsuji M; Ibuki N; Koyama K; Ubai T; Azuma H; Katsuoka Y Int J Clin Oncol; 2010 Dec; 15(6):594-600. PubMed ID: 20422244 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]